Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Mouse (Murine) HGF Anticorps:
anti-Rat (Rattus) HGF Anticorps:
anti-Human HGF Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Mouse (Murine) Polyclonal HGF Primary Antibody pour WB - ABIN3042443
Zhang, Wang, Ma, Liu, Zhang, Zhu: Effect of herba centellae on the expression of HGF and MCP-1. dans Experimental and therapeutic medicine 2013
Show all 7 Pubmed References
Human Polyclonal HGF Primary Antibody pour ICC, IHC (fro) - ABIN4886615
Wen, Zhou, Zhou, Zhou, Luo, Ma: Change in hepatocyte growth factor concentration promote mesenchymal stem cell-mediated osteogenic regeneration. dans Journal of cellular and molecular medicine 2012
Show all 7 Pubmed References
Human Polyclonal HGF Primary Antibody pour IF (p), IHC (p) - ABIN736551
Yu, He, Jiang, He, Fan, Wang, Geng, Dong: Expression and tissue distribution of hepatocyte growth factor (HGF) and its receptor (c-Met) in alpacas (Vicugna pacos) skins associated with white and brown coat colors. dans Acta histochemica 2015
Show all 5 Pubmed References
Cow (Bovine) Polyclonal HGF Primary Antibody pour IHC, WB - ABIN2781816
Kitajima, Ide, Ohtsuka, Miyazaki: Induction of hepatocyte growth factor activator gene expression under hypoxia activates the hepatocyte growth factor/c-Met system via hypoxia inducible factor-1 in pancreatic cancer. dans Cancer science 2008
Show all 6 Pubmed References
Human Polyclonal HGF Primary Antibody pour IHC (f), ICC - ABIN966282
Gohda, Tsubouchi, Nakayama, Hirono, Sakiyama, Takahashi, Miyazaki, Hashimoto, Daikuhara: Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. dans The Journal of clinical investigation 1988
Show all 3 Pubmed References
Human Polyclonal HGF Primary Antibody pour FACS, IHC (p) - ABIN388462
Ryugo, Sawa, Ono, Fukushima, Aleshin, Mizuno, Nakamura, Matsuda: Myocardial protective effect of human recombinant hepatocyte growth factor for prolonged heart graft preservation in rats. dans Transplantation 2004
Show all 7 Pubmed References
Human Polyclonal HGF Primary Antibody pour PLA, WB - ABIN516424
Ogunwobi, Liu: Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways. dans Clinical & experimental metastasis 2011
Human Monoclonal HGF Primary Antibody pour IHC (p), IHC - ABIN438999
Puzio-Kuter, Laddha, Castillo-Martin, Sun, Cordon-Cardo, Chan, Levine: Involvement of tumor suppressors PTEN and p53 in the formation of multiple subtypes of liposarcoma. dans Cell death and differentiation 2015
Human Monoclonal HGF Primary Antibody pour ELISA, IHC - ABIN251141
Lin, Teo, Lam, Jeyaseelan, Wang: MicroRNA-10b pleiotropically regulates invasion, angiogenicity and apoptosis of tumor cells resembling mesenchymal subtype of glioblastoma multiforme. dans Cell death & disease 2012
Human Polyclonal HGF Primary Antibody pour ELISA, WB - ABIN561254
Bouazza, Kratassiouk, Gjata, Perie, Lacau St Guily, Butler-Browne, Svinartchouk: Analysis of growth factor expression in affected and unaffected muscles of oculo-pharyngeal muscular dystrophy (OPMD) patients: a pilot study. dans Neuromuscular disorders : NMD 2009
Met has a role in promoting formation of double minute chromosomes induced by Sei-1 (Montrer SERTAD1 Anticorps) in NIH-3T3 murine fibroblasts
Genetic activation of the antioxidant transcription factor Nrf2 improves liver damage and repair in hepatocyte-specific c-met-deficient mice mainly through restoring a balance in the cellular redox homeostasis.
MET promoted the development of squamous tumors by stimulating the synthesis and release of ligands that activate the epidermal growth factor receptor (EGFR (Montrer EGFR Anticorps)).
through the activation of EGFR, MET activation parallels a RAS pathway to contribute to human and mouse cutaneous cancers.
Results show that c-MET expression is significantly low in pancreatic neuroendocrine tumors (PNETs) and is under the regulation of Meg3-mediated transcriptional and epigenetic mechanisms which contributes to the pathogenesis of PNETs.
Findings indicate a role for the hepatocyte growth factor receptor HGFR/c-MET pathway in neutrophil recruitment and function and suggest that c-MET inhibitor co-treatment may improve responses to cancer immunotherapy in settings beyond c-MET-dependent tumors.
Results demonstrate a new mechanism for the modulation of synapse formation, whereby MET activation induces an alignment of presynaptic and postsynaptic elements that are necessary for assembly and formation of functional synapses by subsets of neocortical neurons that express MET/beta-catenin (Montrer CTNNB1 Anticorps) complex.
MET signaling regulates intestinal homeostasis and regeneration, as well as adenoma formation. These activities of MET are promoted by the stem cell CD44 (Montrer CD44 Anticorps) isoform CD44v4-10.
a c-Met/ETS-1 (Montrer ETS1 Anticorps)/matrix metalloproteinase-14 (MMP-14 (Montrer MMP14 Anticorps)) axis that controls VE-cadherin (Montrer CDH5 Anticorps) degradation, endothelial mesenchymal transition, and vascular abnormality.
Our results show that BMF (Montrer BMF Anticorps)-derived IL-6/HGF and cancer cell-derived TGF-b1 mediate the interactions between bone marrow-derived myofibroblasts and gastric cancer cells, which regulate cancer stemness and promote tumorigenesis.
The results suggested that HGF may inhibit TEMT (Montrer INMT Anticorps) by inhibiting AngII through the JAK2 (Montrer JAK2 Anticorps)/STAT3 (Montrer STAT3 Anticorps) signaling pathway in HK2 (Montrer HK2 Anticorps) cells and HGF may prevent apoptosis induced by AngII. The present study provides a basis for understanding the mechanisms involved in the inhibition of TEMT (Montrer INMT Anticorps) by HGF, which requires further investigation
The identification of novel small-molecule inhibitors of microtubule polymerization highlights the role of the microtubule cytoskeleton in HGF-induced epithelial scattering.
miRNA-200a expression was inverse correlation with HGF expression in stromal fibroblasts. High miRNA-200a and low HGF expression in stromal fibroblasts may predict a good prognosis in patients with non-small cell lung cancer.
Activation of proHGF by St14 (Montrer ST14 Anticorps) induces mouse embryonic stem cell differentiation.
Study shows that Met and HGF have a multi-factorial relationship to the biology and outcome of breast cancer, influenced by gene copy number and protein expression, activation status, stromal environment, and cellular localisation.
These results reveal the effect of HGF on the distinct pathways of eosinophil secretory functions and also provide novel insights into the role of HGF in the pathogenesis of allergic inflammation.
The hepatocyte growth factor (HGF)-MET receptor tyrosine kinase (Montrer RET Anticorps) signaling pathway
MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA (Montrer VEGFA Anticorps), VEGFR1 (Montrer FLT1 Anticorps), VEGFR2 (Montrer KDR Anticorps), HGF and MMP2 (Montrer MMP2 Anticorps)
High HGF expression is associated with castration-resistant progression in androgen dependent metastatic prostate cancer.
miR (Montrer MLXIP Anticorps)-26a/mir (Montrer MLXIP Anticorps)-26b could suppress tumorigenesis and angiogenesis by targeting the HGF-VEGF (Montrer VEGFA Anticorps) axis, and could serve as a potential treatment modality for targeted therapy in the clinical treatment of gastric cancer.
acute pulmonary embolism associated with an enhanced HGF expression in the lungs, the right ventricle, and the liver
SNPs within bovine HGF gene were significantly associated with growth traits. This will provide a background for application of bovine HGF gene in the selection program in Chinese cattle.
Treatment of the bovine satellite cells (BSC (Montrer SLC12A2 Anticorps)) with ephrin-A5 (Montrer EFNA5 Anticorps) causes a reduction in velocity with a concomitant increase in directed migration. Treatment of BSC (Montrer SLC12A2 Anticorps) with hepatocyte growth factor had no immediate effect on cell motility or migration.
HGF transiently increases gene transcription of angiotensin-converting enzyme (Montrer ACE Anticorps)
Combined administration of mesenchymal stem cells overexpressing IGF-1 (Montrer IGF1 Anticorps) and HGF enhances neovascularization but moderately improves cardiac regeneration in a porcine model.
In an animal model of acute myocardial infarction relevant to human disease, intracoronary administration of IGF-1 (Montrer IGF1 Anticorps)/hepatocyte growth factor (HGF) is a practical and effective strategy to reduce pathological cardiac remodeling.
Hepatocyte growth factor regulates cell growth, cell motility, and morphogenesis by activating a tyrosine kinase signaling cascade after binding to the proto-oncogenic c-Met receptor. Hepatocyte growth factor is secreted by mesenchymal cells and acts as a multi-functional cytokine on cells of mainly epithelial origin. Its ability to stimulate mitogenesis, cell motility, and matrix invasion gives it a central role in angiogenesis, tumorogenesis, and tissue regeneration. It is secreted as a single inactive polypeptide and is cleaved by serine proteases into a 69-kDa alpha-chain and 34-kDa beta-chain. A disulfide bond between the alpha and beta chains produces the active, heterodimeric molecule. The protein belongs to the plasminogen subfamily of S1 peptidases but has no detectable protease activity. Alternative splicing of this gene produces multiple transcript variants encoding different isoforms.
hepatocyte growth factor
, scatter factor
, fibroblast-derived tumor cytotoxic factor
, lung fibroblast-derived mitogen
, hepapoietin A
, HGF alpha-chain
, hepatocyte growth factor /scatter factor
, HGF receptor
, HGF/SF receptor
, SF receptor
, hepatocyte growth factor receptor
, met proto-oncogene tyrosine kinase
, proto-oncogene c-Met
, scatter factor receptor
, tyrosine-protein kinase Met